tesamorelin

Tesamorelin is a growth-hormone-releasing-hormone (GHRH) pathway peptide. It is FDA-approved to reduce visceral fat in people with HIV-related lipodystrophy. 1 2

• Reported benefits: People using growth-hormone-releasing peptides report better sleep, skin tone and texture, and workout recovery or durability; these are reported effects, not a guarantee of benefit. 3
• Differences by sex: One physician described tesamorelin as seeming to work better in females than males, based on his clinical observations. 4
• Natural production and lasting effects: Repeated use of growth-hormone-related peptides may suppress the body's own signaling, and some peptides may alter gene expression in ways that persist after stopping. The discussion raises this as a potential concern rather than establishing how often or how long such effects occur. 5